Medhealth insight

X-twitter Linkedin Facebook

eClinical Trial Management

eClinical Trial Management

Oral Semaglutide Greatly Lowers Heart Attack & Stroke Risk in Type 2 Diabetes

Semaglutide, a glucagon-like peptide-1 receptor agonist, has gained recognition for its role in managing weight, blood sugar, and even alcohol cravings. Both its injectable and oral forms have been...

Trending News

Marea Therapeutics to Present Late-Breaking Data...

News
Marea Therapeutics, Inc., a clinical-stage biotechnology...

Zydus Lifesciences Expands into France with...

News
Zydus Lifesciences Limited (BSE: 532321, NSE:...

BioDuro Launches New R&D and Manufacturing...

Clinical Stage Biopharmaceutical
BioDuro is expanding its global contract...

New Chemistry Method Uses Coconut Oil...

Chemical Tech
Researchers at the University of Missouri,...

Eli Lilly Debuts Mounjaro in India,...

News
Eli Lilly has launched its diabetes...